A new CSP position was established today on Teva Pharmaceutical Industries Ltd (TEVA). All prices include IB commissions.
| Criteria | Value |
|---|
| Dividend Champions Status | Contender |
| Years of Consecutive Dividend Increases | 13 |
| Fair Value Estimate | $58.00 |
| Target Buy Price | $40.60 |
| Target Margin of Safety | 30.00% |
| Actual Buy Price | $40.00 |
| Actual Margin of Safety | 31.03% |
| Date | Stock | Description | Transaction | Status | Stock Investment | Income Generated |
|---|
| 3/22/2012 | TEVA | CSP Margin Used | CSP 100 TEVA @ 40.00 | | ($4,000.00) | |
| 3/22/2012 | TEVA | Initial Put Option | STO 1 May12 40.00 Put @ 0.51 | | | $50.97 |
Position Summary
| Cost Basis | ($4,000.00) |
| Income Generated | $50.97 |
| Percent Income Generated | 1.27% |
| Annualized Income Generated | 8.16% |
| Net Profit If Assigned | $50.97 |
| Percent Return If Assigned | 1.27% |
| Annualized Return If Assigned | 8.16% |
| Days Held to Expiration | 57 days |
